Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (31-40 of 302) with videos related to

Pageof 31
Sort By:
Expert Opinion on Investigational Drugs|July 4, 2015
Ixazomib for the treatment of multiple myelomaMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Cancers|January 10, 2026
Trends in Survival and Mortality of "Early" Metastatic Breast Cancer in Northern Italy Following the Introduction of Targeted TherapiesFrancesco Marinelli, Maria Barbara Braghiroli, Isabella Bisceglia, et al.
Leukemia Research|April 28, 2004
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patientsSara Galimberti, Francesca Guerrini, Giuseppe Alberto Palumbo, et al.
Expert Opinion on Biological Therapy|May 17, 2024
Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literatureEmiliano Barbieri, Enrica Antonia Martino, Elena Rivolti, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
Expert Opinion on Biological Therapy|December 25, 2015
The role of tandem stem cell transplantation for multiple myeloma patientsMassimo Martino, Anna Grazia Recchia, Roberta Fedele, et al.
European Journal of Haematology|October 27, 2024
Comparative Analysis of Bispecific Antibodies and CAR T-Cell Therapy in Follicular LymphomaFortunato Morabito, Enrica Antonia Martino, Maria Elena Nizzoli, et al.
Cancers|June 28, 2023
Changes in the Histology of Lung Cancer in Northern Italy: Impact on Incidence and MortalityLucia Mangone, Francesco Marinelli, Isabella Bisceglia, et al.
Leukemia & Lymphoma|January 19, 2008
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Gaetano Vitelli, Giovanna Cutrona, et al.
Frontiers in Oncology|July 12, 2019
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical PracticeSara Galimberti, Elisa Genuardi, Francesco Mazziotta, et al.
Pageof 31

Showing results (31-40 of 302) with videos related to

Sort By:
Pageof 31
Expert Opinion on Investigational Drugs|July 4, 2015
Ixazomib for the treatment of multiple myelomaMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Cancers|January 10, 2026
Trends in Survival and Mortality of "Early" Metastatic Breast Cancer in Northern Italy Following the Introduction of Targeted TherapiesFrancesco Marinelli, Maria Barbara Braghiroli, Isabella Bisceglia, et al.
Leukemia Research|April 28, 2004
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patientsSara Galimberti, Francesca Guerrini, Giuseppe Alberto Palumbo, et al.
Expert Opinion on Biological Therapy|May 17, 2024
Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literatureEmiliano Barbieri, Enrica Antonia Martino, Elena Rivolti, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
Expert Opinion on Biological Therapy|December 25, 2015
The role of tandem stem cell transplantation for multiple myeloma patientsMassimo Martino, Anna Grazia Recchia, Roberta Fedele, et al.
European Journal of Haematology|October 27, 2024
Comparative Analysis of Bispecific Antibodies and CAR T-Cell Therapy in Follicular LymphomaFortunato Morabito, Enrica Antonia Martino, Maria Elena Nizzoli, et al.
Cancers|June 28, 2023
Changes in the Histology of Lung Cancer in Northern Italy: Impact on Incidence and MortalityLucia Mangone, Francesco Marinelli, Isabella Bisceglia, et al.
Leukemia & Lymphoma|January 19, 2008
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Gaetano Vitelli, Giovanna Cutrona, et al.
Frontiers in Oncology|July 12, 2019
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical PracticeSara Galimberti, Elisa Genuardi, Francesco Mazziotta, et al.
Pageof 31